# Alexander M.M. Eggermont

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexander-m-m-eggermont/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,848 |
| Field | Cutaneous Melanoma Detection and Management |
| h-index | 104 |
| i10-index | 385 |
| Last Known Institution | University Medical Center Utrecht |
| OpenAlex ID | https://openalex.org/A5052579165 |
| ORCID iD | https://orcid.org/0000-0002-4278-040X |
| Works | 640 |

## Researcher papers

- [Final Version of 2009 AJCC Melanoma Staging and Classification](https://scholariq.org/papers/final-version-of-2009-ajcc-melanoma-staging-and-classification/)
- [Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma/)
- [Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma](https://scholariq.org/papers/reversible-and-adaptive-resistance-to-braf-v600e-inhibition-in-melanoma/)
- [The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes](https://scholariq.org/papers/the-pd-1-pd-l1-checkpoint-restrains-t-cell-immunity-in-tumor-draining-lymph/)
- [Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016](https://scholariq.org/papers/diagnosis-and-treatment-of-melanoma-european-consensus-based-interdisciplinary/)
- [Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases](https://scholariq.org/papers/multivariate-analysis-of-prognostic-factors-among-2-313-patients-with-stage-iii/)
- [European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment](https://scholariq.org/papers/european-interdisciplinary-guideline-on-invasive-squamous-cell-carcinoma-of-the/)
- [Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?](https://scholariq.org/papers/clinical-relevance-of-melanoma-micrometastases-and-lt-0-1-mm-in-sentinel-nodes/)
- [Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients](https://scholariq.org/papers/sentinel-node-tumor-burden-according-to-the-rotterdam-criteria-is-the-most/)

## Researcher topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [University Medical Center Utrecht](https://scholariq.org/institutions/university-medical-center-utrecht/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.